Table 2 Distribution of clinical centers where the 6031 enrolled nasopharyngeal carcinoma patients received a biopsy and therapy
From: A new prognostic histopathologic classification of nasopharyngeal carcinoma
Center for biopsy | Center for therapy | Number of cases |
|---|---|---|
Department of Pathology, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, Guangdong, China | Department of Radiation Oncology, SYSUCC | 4329 |
Department of Pathology, multiple local centers in Guangdong, China | Department of Radiation Oncology, SYSUCC | 504 |
Department of Pathology, Guangxi Medical University Cancer Center, Nanning, Guangxi, China | Department of Radiation Oncology, Guangxi Medical University Cancer Center | 204 |
Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS), Beijing, China | Department of Radiation Oncology, Cancer Hospital, CAMS | 100 |
Department of Pathology, The Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China | Department of Radiation Oncology, The Affiliated Hospital of Bengbu Medical College | 113 |
Department of Pathology, Hunan Provincial Cancer Hospital, Changsha, Hunan, China | Department of Radiation Oncology, Hunan Provincial Cancer Hospital | 130 |
Department of Pathology, Fujian Provincial Tumor Hospital, Fuzhou, Fujian, China | Department of Radiation Oncology, Fujian Provincial Tumor Hospital | 47 |
Department of Anatomical and Cellular Pathology, Faculty of Medicine, the Chinese University of Hong Kong (CUHK), Hong Kong, China | Department of Clinical Oncology, CUHK | 207 |
Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan | Department of Otolaryngology, National Taiwan University Hospital | 211 |
Department of Pathology, Singapore General Hospital, Singapore, Singapore | Department of Radiation Oncology, National Cancer Center, Singapore | 186 |